An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity Against a Broad Range of Solid Tumors

Cancer Research - United States
doi 10.1158/0008-5472.can-13-2440
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Antibody–Drug Conjugate Hits Elusive HER2 + Breast Tumors

Cancer Discovery
Oncology
2013English

An IL13Rα2 Peptide Exhibits Therapeutic Activity Against Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

ABBV-399, a C-Met Antibody–Drug Conjugate That Targets Both MET –Amplified and C-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

Clinical Cancer Research
Cancer ResearchOncology
2016English

Functional Relevance of in Vivo Half Antibody Exchange of an IgG4 Therapeutic Antibody-Drug Conjugate

PLoS ONE
Multidisciplinary
2018English

Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Cancer Research
Cancer ResearchOncology
2016English

A Neutralizing Anti-Fibroblast Growth Factor 8 Monoclonal Antibody Shows Potent Antitumor Activity Against Androgen-Dependent Mouse Mammary Tumors in Vivo

Clinical Cancer Research
Cancer ResearchOncology
2005English

LGR5-Targeted Antibody-Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

VEGFR2 Targeted Antibody Fused With MICA Stimulates NKG2D Mediated Immunosurveillance and Exhibits Potent Anti-Tumor Activity Against Breast Cancer

Oncotarget
Oncology
2016English

Intracellular Catabolism of an Antibody Drug Conjugate With a Noncleavable Linker

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy